L.O.M. Medical International
Inc.
Newsletter & Update
Volume 3, Issue 4
Page 1
October/November 1999
From The
President?s Desk
Our Valued Shareholders: I would like to take this
opportunity to update you on some of the events that have
taken place since our last Newsletter. These events are
very exciting and encouraging for a start-up Company such
as L.O.M. Medical International.
We are attracting high profile investors who are well
known by the medical industry, as well as medical
publishing journals that very often influence the brokerages
and market makers who are out there promoting our stock
to the various fund managers. This is becoming more
evident as the company is getting closer to trading.
At our September 25th , 1999 Board of Directors
Meeting held in our Vancouver Office, I reported our
position to the Board in regards to trading. The company is
presently cleared to commence trading, and can do so,
once the Board gives me the vote to go ahead and trade.
The Board reminded me that certain objectives would
have to be met before their approval to commence trading
can be given, namely that the Offering Memorandum for
the one million shares at $5.00 U.S. be placed. The
Boards position on this matter was well supported at the
Annual Shareholders Meeting, which was held in Kelowna
on April 23, 1999.
There are several companies we are negotiating with
regarding the placement. L.O.M. Medical is currently
negotiating with a New Jersey brokerage firm, who are
major market makers for the Eastern United States.
Sincerely,
John Klippenstein,
President & CEO
L.O.M.
Medical
International
Inc. is proud
to announce
the signing of
a contract
with Health
Care Insights
of Edison,
New Jersey.
Dr. Jeffrey Berg CEO of Health
Care Insights attended a meeting at
our Kelowna Office on October
12th, 1999 at which time the
agreement was completed. Dr.Berg
will be the prime consultant to
L.O.M. Medical International Inc.
on Product Analysis and valuations
as well as strategic alliances with
other Medical Corporations.
Dr. Berg is a senior Research
Analyst who has a Ph.D. in
Chemistry and an MBA. He's a
regular contributor to major
American Medical Publications and
is well respected in the Medical and
Health care industry. He specializes
in Pharmaceutical, Biotechnology,
Medical Devises, and Diagnostic
Products, he primarily focuses on
emerging growth Companies. Dr.
Berg has a broad and extensive
background as prime consultant to
major Medical Companies and is
well known in the Industry
worldwide.
H.M. Meyerson & Co. of New
Jersey use Dr. Jeffrey Berg as their
senior analyst for new and emerging
Medical Technology and
Biotechnology Companies. It was
at the recommendation of H.M
Meyerson that L.O.M. Medical
International Inc. got its introduction
to Dr. Berg. L.O.M. Medical
International Inc. Stock will be
offered through H.M. Meyerson of
New Jersey as Market Maker for
the Eastern part of the United
States. Alexander & Company will
be L.O.M.`s Market Maker for the
Pacific Western part of the United
States.
We'd like To Know: At
L.O.M. we are always concerned
about hearing from you! Our
Shareholders are an important part
of our Company, and we are
interested in receiving your input
and comments. Please e-mail your
comments or suggestions to our
offices. Hope to hear from you
soon! ...Directors & Staff
bcjt |
